CD8A and Merkel cell skin cancer: Both virus-positive (VP) and virus-negative (VN) MCC are immunogenic and can elicit MCC-specific CD8+ and CD4+ T cell responses [4, 5], and most patients with VP-MCC mount a B cell response against the MCPyV T-antigen oncoproteins [6, 7].